(Q34451883)

2 August 2017

1 reference

title

Current developments in malaria transmission-blocking vaccines (English)

1 reference

2 August 2017

0 references

1 reference

2

Carter R

1 reference

2 August 2017

Stowers A

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

619-628

1 reference

Transmission-blocking immunity against malaria and other vector-borne diseases

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Transmission-blocking vaccines: uses and current status of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Immune effector mechanisms in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Successful immunization against the sexual stages of Plasmodium gallinaceum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Malaria transmission blocked by immunisation with gametes of the malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Evidence for a mass community effect of insecticide-treated bednets on the incidence of malaria on the Kenyan coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Malaria parasite chitinase and penetration of the mosquito peritrophic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Disruption of the Pfg27 locus by homologous recombination leads to loss of the sexual phenotype in P. falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Plasmodium falciparum sexual stage antigens: Immunogenicity and cell-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Minimal variation in a vaccine candidate from the sexual stage of plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

Plasmodium falciparum: An abundant stage-specific protein expressed during early gametocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.619

21 January 2018

Identifiers

DOI

10.1517/14712598.1.4.619

1 reference

2 August 2017

1 reference